NASDAQ:OM - Outset Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $58.20
  • Forecasted Upside: 19.68 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$48.63
▼ -0.49 (-1.00%)
1 month | 3 months | 12 months
Get New Outset Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OM

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$58.20
▲ +19.68% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Outset Medical in the last 3 months. The average price target is $58.20, with a high forecast of $63.00 and a low forecast of $54.00. The average price target represents a 19.68% upside from the last price of $48.63.

Buy

The current consensus among 8 contributing investment analysts is to buy stock in Outset Medical.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/17/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/16/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/16/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/15/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/6/2021Morgan StanleyBoost Price TargetEqual Weight$58.00 ➝ $60.00High
i
4/19/2021Wells Fargo & CompanyInitiated CoverageOverweight$63.00Low
i
3/10/2021Morgan StanleyBoost Price TargetEqual Weight$52.00 ➝ $58.00Low
i
12/16/2020OppenheimerInitiated CoverageMarket PerformLow
i
12/15/2020OppenheimerInitiated CoverageMarket PerformMedium
i
12/15/2020Morgan StanleyBoost Price TargetEqual Weight$48.00 ➝ $52.00Low
i
10/12/2020BarclaysInitiated CoverageOverweightHigh
i
10/12/2020Morgan StanleyInitiated CoverageEqual Weight$48.00Low
i
10/12/2020Stifel NicolausInitiated CoverageBuy$54.00Low
i
10/12/2020SVB LeerinkInitiated CoverageMarket Perform$60.00Low
i
Rating by D. Antalffy at SVB Leerink LLC
10/12/2020Bank of AmericaInitiated CoverageBuyLow
i
10/12/2020The Goldman Sachs GroupInitiated CoverageBuy$54.00Low
i
(Data available from 6/14/2016 forward)
Outset Medical logo
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Read More

Today's Range

Now: $48.63
$48.52
$50.12

50 Day Range

MA: $50.89
$41.49
$59.92

52 Week Range

Now: $48.63
$41.07
$66.96

Volume

496,573 shs

Average Volume

418,220 shs

Market Capitalization

$2.24 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Outset Medical?

The following sell-side analysts have issued research reports on Outset Medical in the last year: Bank of America Co., Barclays PLC, Morgan Stanley, Oppenheimer Holdings Inc., Stifel Nicolaus, SVB Leerink LLC, The Goldman Sachs Group, Inc., Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for OM.

What is the current price target for Outset Medical?

5 Wall Street analysts have set twelve-month price targets for Outset Medical in the last year. Their average twelve-month price target is $58.20, suggesting a possible upside of 18.0%. Wells Fargo & Company has the highest price target set, predicting OM will reach $63.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $54.00 for Outset Medical in the next year.
View the latest price targets for OM.

What is the current consensus analyst rating for Outset Medical?

Outset Medical currently has 3 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OM will outperform the market and that investors should add to their positions of Outset Medical.
View the latest ratings for OM.

What other companies compete with Outset Medical?

How do I contact Outset Medical's investor relations team?

Outset Medical's physical mailing address is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. The company's listed phone number is 669 231 8200 and its investor relations email address is [email protected] The official website for Outset Medical is outsetmedical.com.